Morgan Stanley’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $223M | Buy |
2,591,503
+561,688
| +28% | +$49.3M | 0.01% | 969 |
|
|
2026
Q1 | $184M | Buy |
2,029,815
+191,719
| +10% | +$17.6M | 0.01% | 1010 |
|
|
2025
Q4 | $165M | Buy |
1,838,096
+144,789
| +9% | +$13.7M | 0.01% | 1059 |
|
|
2025
Q3 | $167M | Sell |
1,693,307
-144,977
| -8% | -$14.4M | 0.01% | 1036 |
|
|
2025
Q2 | $168M | Sell |
1,838,284
-247,360
| -12% | -$23.9M | 0.01% | 962 |
|
|
2025
Q1 | $236M | Sell |
2,085,644
-66,621
| -3% | -$7.13M | 0.02% | 757 |
|
|
2024
Q4 | $227M | Buy |
2,152,265
+103,428
| +5% | +$11.1M | 0.02% | 773 |
|
|
2024
Q3 | $221M | Sell |
2,048,837
-360,757
| -15% | -$39.4M | 0.02% | 774 |
|
|
2024
Q2 | $262M | Buy |
2,409,594
+188,617
| +8% | +$22.2M | 0.02% | 677 |
|
|
2024
Q1 | $293M | Sell |
2,220,977
-559,108
| -20% | -$69.8M | 0.02% | 634 |
|
|
2023
Q4 | $338M | Buy |
2,780,085
+301,394
| +12% | +$33.6M | 0.03% | 551 |
|
|
2023
Q3 | $278M | Sell |
2,478,691
-807,806
| -25% | -$103M | 0.03% | 576 |
|
|
2023
Q2 | $479M | Buy |
3,286,497
+4,709
| +0.1% | +$640K | 0.05% | 379 |
|
|
2023
Q1 | $424M | Buy |
3,281,788
+179,359
| +6% | +$22.5M | 0.05% | 407 |
|
|
2022
Q4 | $396M | Buy |
3,102,429
+1,384,068
| +81% | +$161M | 0.04% | 417 |
|
|
2022
Q3 | $180M | Sell |
1,718,361
-5,216
| -0.3% | -$572K | 0.02% | 614 |
|
|
2022
Q2 | $181M | Buy |
1,723,577
+918,447
| +114% | +$109M | 0.02% | 629 |
|
|
2022
Q1 | $103M | Sell |
805,130
-239,831
| -23% | -$28.9M | 0.01% | 845 |
|
|
2021
Q4 | $129M | Buy |
1,044,961
+91,364
| +10% | +$12M | 0.02% | 749 |
|
|
2021
Q3 | $136M | Sell |
953,597
-551
| -0.1% | -$81.1K | 0.02% | 678 |
|
|
2021
Q2 | $149M | Buy |
954,148
+77,501
| +9% | +$12.6M | 0.02% | 651 |
|
|
2021
Q1 | $136M | Buy |
876,647
+176,091
| +25% | +$27.3M | 0.02% | 627 |
|
|
2020
Q4 | $105M | Sell |
700,556
-406
| -0.1% | -$57.3K | 0.02% | 700 |
|
|
2020
Q3 | $92.6M | Buy |
700,962
+55,265
| +9% | +$7.22M | 0.02% | 614 |
|
|
2020
Q2 | $74.8M | Buy |
645,697
+30,171
| +5% | +$3.48M | 0.02% | 654 |
|
|
2020
Q1 | $60.4M | Sell |
615,526
-40,045
| -6% | -$5.25M | 0.02% | 664 |
|
|
2019
Q4 | $95.3M | Buy |
655,571
+63,875
| +11% | +$8.82M | 0.02% | 630 |
|
|
2019
Q3 | $78.9M | Sell |
591,696
-74,700
| -11% | -$9.65M | 0.02% | 646 |
|
|
2019
Q2 | $76.2M | Buy |
666,396
+126,780
| +23% | +$14.8M | 0.02% | 656 |
|
|
2019
Q1 | $66.9M | Sell |
539,616
-483,029
| -47% | -$54.9M | 0.02% | 693 |
|
|
2018
Q4 | $103M | Buy |
1,022,645
+318,265
| +45% | +$35.8M | 0.03% | 513 |
|
|
2018
Q3 | $89.9M | Sell |
704,380
-367,775
| -34% | -$43.7M | 0.02% | 646 |
|
|
2018
Q2 | $116M | Buy |
1,072,155
+173,871
| +19% | +$18.9M | 0.03% | 513 |
|
|
2018
Q1 | $95.1M | Buy |
898,284
+49,422
| +6% | +$5.74M | 0.03% | 612 |
|
|
2017
Q4 | $99.5M | Buy |
848,862
+52,691
| +7% | +$5.96M | 0.03% | 595 |
|
|
2017
Q3 | $90.5M | Buy |
796,171
+97,494
| +14% | +$11.3M | 0.03% | 608 |
|
|
2017
Q2 | $87.1M | Sell |
698,677
-95,928
| -12% | -$11.4M | 0.03% | 621 |
|
|
2017
Q1 | $94.2M | Buy |
794,605
+133,165
| +20% | +$15.1M | 0.03% | 593 |
|
|
2016
Q4 | $66.3M | Sell |
661,440
-72,485
| -10% | -$7.77M | 0.02% | 718 |
|
|
2016
Q3 | $92.6M | Buy |
733,925
+215,791
| +42% | +$26.7M | 0.03% | 555 |
|
|
2016
Q2 | $60.6M | Buy |
518,134
+145,093
| +39% | +$16.4M | 0.02% | 704 |
|
|
2016
Q1 | $38.6M | Buy |
373,041
+17,140
| +5% | +$1.66M | 0.01% | 902 |
|
|
2015
Q4 | $35.5M | Buy |
355,901
+63,964
| +22% | +$6.26M | 0.01% | 1006 |
|
|
2015
Q3 | $26.6M | Sell |
291,937
-234,740
| -45% | -$23.5M | 0.01% | 1172 |
|
|
2015
Q2 | $55.9M | Buy |
526,677
+59,925
| +13% | +$6.63M | 0.02% | 804 |
|
|
2015
Q1 | $53.3M | Sell |
466,752
-523,548
| -53% | -$59.7M | 0.02% | 821 |
|
|
2014
Q4 | $109M | Buy |
990,300
+168,676
| +21% | +$17.8M | 0.04% | 478 |
|
|
2014
Q3 | $80.2M | Buy |
821,624
+69,669
| +9% | +$6.85M | 0.03% | 606 |
|
|
2014
Q2 | $75.8M | Buy |
751,955
+476,373
| +173% | +$46.5M | 0.03% | 610 |
|
|
2014
Q1 | $25.3M | Sell |
275,582
-129,514
| -32% | -$11.9M | 0.01% | 1185 |
|
|
2013
Q4 | $36.7M | Buy |
405,096
+217,123
| +116% | +$18.8M | 0.02% | 912 |
|
|
2013
Q3 | $15M | Sell |
187,973
-128,407
| -41% | -$10.1M | 0.01% | 1455 |
|
|
2013
Q2 | $23M | Buy |
+316,380
| New | +$23.7M | 0.01% | 1085 |
|
Other funds holding ZBH
Morgan Stanley's ZBH Position: Q2 2026 in Review
Morgan Stanley increased its Zimmer Biomet (ZBH) stake by 28% in Q2 2026, buying an estimated $49.3M and bringing the position to 2,591,503 shares worth $223M. The position accounts for 0.01% of the portfolio, ranked #969.
Morgan Stanley first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $479M in Q2 2023. 907 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Morgan Stanley held 2,591,503 shares of Zimmer Biomet worth $223M as of Q2 2026.
- Morgan Stanley bought 561,688 Zimmer Biomet shares in Q2 2026, an estimated $49.3M.
- Zimmer Biomet made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #969 holding.
- Morgan Stanley first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
- Morgan Stanley's Zimmer Biomet position peaked at $479M in Q2 2023.
- 907 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.